| ARO:3003074-YP_500802.1 |
cls |
Staphylococcus aureus subsp. aureus NCTC 8325 |
daptomycin;
peptide
|
| ARO:3003285-YP_039996.1 |
rpoB |
Staphylococcus aureus subsp. aureus MRSA252 |
peptide;
rifabutin;
rifampin;
rifamycin;
rifapentine;
rifaximin
|
| ARO:3003287-YP_039996.1 |
rpoB |
Staphylococcus aureus subsp. aureus MRSA252 |
peptide;
rifamycin
|
| ARO:3003291-YP_039997.1 |
rpoC |
Staphylococcus aureus subsp. aureus MRSA252 |
daptomycin;
peptide
|
| ARO:3003296-YP_039483.1 |
gyrA |
Staphylococcus aureus subsp. aureus MRSA252 |
ciprofloxacin;
enoxacin;
fluoroquinolone;
gatifloxacin;
grepafloxacin;
levofloxacin;
lomefloxacin;
moxifloxacin;
nalidixic acid;
norfloxacin;
nybomycin;
ofloxacin;
pefloxacin;
sparfloxacin;
trovafloxacin
|
| ARO:3003301-YP_039482.1 |
gyrB |
Staphylococcus aureus subsp. aureus MRSA252 |
aminocoumarin;
clorobiocin;
coumermycin A1;
novobiocin
|
| ARO:3003312-YP_040772.1 |
parC |
Staphylococcus aureus subsp. aureus MRSA252 |
ciprofloxacin;
enoxacin;
fluoroquinolone;
gatifloxacin;
grepafloxacin;
levofloxacin;
lomefloxacin;
moxifloxacin;
nalidixic acid;
norfloxacin;
ofloxacin;
pefloxacin;
sparfloxacin;
trovafloxacin
|
| ARO:3003314-BAA11086.1 |
parE |
Staphylococcus aureus RN4220 |
aminocoumarin;
clorobiocin;
coumermycin A1;
novobiocin
|
| ARO:3003315-YP_040771.1 |
parE |
Staphylococcus aureus subsp. aureus MRSA252 |
ciprofloxacin;
enoxacin;
fluoroquinolone;
gatifloxacin;
grepafloxacin;
levofloxacin;
lomefloxacin;
moxifloxacin;
nalidixic acid;
norfloxacin;
ofloxacin;
pefloxacin;
sparfloxacin;
trovafloxacin
|
| ARO:3003319-ADJ67256 |
mprF |
Staphylococcus aureus |
daptomycin;
peptide
|
| ARO:3003323-WP_001025093 |
pgsA |
Staphylococcus aureus |
daptomycin;
peptide
|
| ARO:3003729-CAA52296.1 |
ileS |
Staphylococcus aureus |
mupirocin
|
| ARO:3003735-CAG39573 |
fusA |
Staphylococcus aureus subsp. aureus MRSA252 |
fusidic acid
|
| ARO:3003737-ADL24064.1 |
fusE |
Staphylococcus aureus subsp. aureus JKD6159 |
fusidic acid
|
| ARO:3003769-ADJ67256.1 |
mprF |
Staphylococcus aureus |
defensin;
peptide
|
| ARO:3003776-CAG41169.1 |
murA |
Staphylococcus aureus subsp. aureus MRSA252 |
fosfomycin
|
| ARO:3003794-CAG39047 |
walK |
Staphylococcus aureus subsp. aureus MRSA252 |
daptomycin;
peptide
|
| ARO:3003901-CAG39357 |
GlpT |
Staphylococcus aureus subsp. aureus MRSA252 |
fosfomycin
|
| ARO:3003902-CAG39240 |
UhpT |
Staphylococcus aureus subsp. aureus MRSA252 |
fosfomycin
|
| ARO:3003917-YP_499533.1 |
menA |
Staphylococcus aureus subsp. aureus NCTC 8325 |
Lysocin E;
lysocin;
peptide
|
| P0C0Q9 |
DNA gyrase subunit A |
Staphylococcus epidermidis |
ciprofloxacin
|
| P20831 |
DNA gyrase subunit A |
Staphylococcus aureus |
fluoroquinolone
|
| Q2G2Q0 |
DNA gyrase subunit A |
Staphylococcus aureus (strain NCTC 8325) |
fluoroquinolone
|
| P0C1U9 |
parC |
Staphylococcus aureus |
In strain: FDA 574
|
| Q9AIV3 |
mprF |
Staphylococcus aureus |
In strain: KSA8
|
| Q9FBG4 |
cfr |
Staphylococcus sciuri |
No change in activity
|